top of page

Review of Common Conditions 

  • GERD
  • Hiatal Hernia
  • Esophageal Motility Disorders
  • Achalasia
  • Diffuse Esophageal Spasm
  • Nutcracker Esophagus
  • Scleroderma Esophagus
  • Other Esophageal Disorders
  • Eosinophilic Esophagitis
  • Esophageal Diverticula
  • Barretts Esophagus
  • Esophageal Cancer 
  • Non-Small Cell Lung Cancer 
  • Chylothorax
  • Lung Transplantation 

GASTROESOPHAGEAL REFLUX DISEASE (GERD) 

 

Clinical Highlights

  • Pathologic reflux of gastric contents into the thoracic esophagus with or without associated symptoms. Increased exposure of the esophagus to refluxed gastric juice

  • The digestive tract from the esophagus to the stomach functions in much the same way that a plumbing circuit does. The esophagus acts as an antegrade pump, the lower esophageal sphincter (LES) works as a valve, and the stomach functions as a tank. Abnormalities associated with GERD may result from a malfunction of any part of this system

  • Insufficient esophageal motility inhibits clearing of acidic material

  • A    defective    LES    results    in excessive reflux of gastric juice 

  • Delayed   gastric  emptying  can

increase the volume and pressure in the stomach until the LES is no longer functioning, ultimately causing GERD

  • Esophageal  defense mechanisms

  • Mechanical esophageal clearance via  peristalsis

  • Chemical esophageal clearance via saliva

  • Mucosal resistance – mucosa guards against esophagitis and other complications of reflux

Causes:

Dysfunctional LES

  • The LES is the manometric zone of increased intraluminal pressure at the esophagogastric junction

  • Diaphragmatic crura act as an extrinsic sphincter

  • LES dysfunction can occur via:

  • Transient relaxation of the LES (most common)

  • Permanent relaxation of the LES, or complete loss of LES tone

  • Transient increase of intra-abdominal pressure surpassing LES pressure

Delayed Gastric Emptying

  • Delayed gastric emptying leads to accumulation of gastric contents, which increases intra-abdominal pressure. When this pressure exceeds LES pressure, reflux results

Hiatal Hernia

  • The LES may migrate proximally, causing a loss of the abdominal high pressure zone

  • The hernia may widen the hiatus, impairing the ability of the diaphragmatic crus to act as an extrinsic sphincter

  • Gastric contents may be trapped in the hernia sac and reflux proximally during relaxation

Obesity

  • Increased intra-abdominal pressure and gastroesophageal pressure gradient

  • Incompetence of the LES

  • Increased frequency of transient LES relaxation

Risk Factors for GERD

  • Obesity

  • Hiatal hernia

  • Straining that increases intra-abdominal pressure (eg, pregnancy, constipation)

  • Heavy lifting

  • Tobacco abuse

  • Diet high in fats, chocolate, mints, coffee, citrus (unconfirmed)

 

History & Exam

  • Typical

    • Heartburn

    • Regurgitation

    • Dysphagia

  • Atypical

    • Coughing, hoarseness, or sore throat

    • Noncardiac chest pain

    • Enamel erosion or dental manifestations

    • Recurrent chest infections/pneumonia

    • History of nausea or vomiting, bloating/belching, or regurgitation should alert you to evaluate for delayed gastric emptying

 

Workup

  • Esophagogastroduodenoscopy (EGD) – Used to evaluate for strictures, hiatal hernia, or abnormalities of the esophageal mucosa, such as Barrett’s or cancer 

  • Esophageal manometry – Used to evaluate for esophageal dysmotility

  • pH monitoring with Bravo probe or 24-hour pH testing – Used to objectively confirm presence of acid reflux. Data are measured and a composite score is provided (ie, DeMeester score >14.7 is pathologic)

    • Bravo probe– Capsule placed endoscopically at the distal esophagus. Pt. carries a pager- like  device  and  presses  button when symptoms are felt. Results are synthesized, and symptoms and acid exposure are assessed for possible correlation. Probe ultimately detaches and passes in stool

    • 24-hour pH testing– Nasoesophageal tube is put in place for 24 hours. Pt carries a pager-like device and presses button when symptoms are felt. Data are measured at distal and proximal channels – useful to evaluate for proximal reflux in patients with atypical symptoms

 

Management

  • Stepwise approach with goals of controlling symptoms, healing esophagitis, and preventing complications such as recurrent esophagitis and Barrett’s esophagus

  • Lifestyle modifications (see below) and control of gastric acid secretion through medical therapy (eg, antacids, PPIs) or surgery (ie, antireflux procedure)

  • Recommended  lifestyle modifications

    • Lose weight if needed (this is a critical objective for overweight pts)

    • Limit alcohol consumption, stop smoking

    • Limit bending or stooping positions

    • Eat small, frequent meals throughout the day, avoiding spicy foods, chocolate, tomato-based products, peppermint, foods in the onion family, citrus juice, coffee, alcohol, and caffeine

    • Do not eat within 3 hours of bedtime, and sleep with the head of the bed elevated

 

Pharmacology

  • TUMS

  • H2 antagonists (pts. develop tolerance to these drugs)

    • Ranitidine- 150mg BID (Zantac)

    • Famotidine- 20-40mg daily or BID (Pepcid)

  • PPIs (must be taken 30 to 60 minutes before eating)

    • Omeprazole- 40mg daily or BID

    • Pantoprazole- 40mg daily or BID

    • Dexlansoprazole- 30mg daily

    • Lansoprazole- 30mg daily

  • Carafate- Coating agent for esophageal erosions/gastric erosions/ erosive esophagitis. 1g PO QID. Needs to be in liquid form for pts with esophageal problems. Can be expensive

 

Surgery

  • Indications for surgery 

    • Patients whose GERD is inadequately controlled with PPIs

    • Patients with complications of GERD, such as esophagitis, ulcer, or stricture

    • Patients with Barrett’s esophagus or extra-esophageal manifestations:

      • Respiratory symptoms – cough, wheezing, aspiration, recurrent PNA

      • ENT symptoms – hoarseness, sore throat, otitis media

      • Dental symptoms – enamel erosion

    • Young patients

    • Patients who have poor compliance with medications

    • Postmenopausal women with osteoporosis

    • Patients with large HH or symptoms related to hernia, such as chest discomfort, anemia, torsion symptoms (eg, abdominal pain and distention, especially in the upper abdomen)

 

  • Fundoplication – Laparoscopic vs. open (See Guidelines for Fundoplication) Involves:

    • Complete mobilization of the fundus of the stomach with division of the short gastric vessels

    • Right and left hiatal dissection

    • Mobilization of the esophagus

    • Reduction of the hernia

    • Closure of the esophageal hiatus

    • Creation of a fundoplication (ie, wrap)

      • Nissen: 360° posterior wrap

      • Toupet: 270° posterior wrap

      • Dor: partial 180° anterior stabilization

  • Gastric diversion with Roux-en-Y. Indications:

    • Morbidly obese pts

    • Recalcitrant disease with aperistaltic esophagus

    • Multiple redo fundoplications

bottom of page